Anxiety and depression often occur together. When they do, symptoms can overlap and interact, affecting everything from your energy and motivation to sleep, concentration, relationships and daily life.

If you are experiencing both, you may wonder whether treatment has to address them separately or whether one treatment plan can account for your full symptom picture.

TMS therapy may be considered for certain patients experiencing depression with co-occurring anxiety symptoms.

At Neurotherapeutix, treatment planning looks beyond diagnosis alone. We use functional brain imaging and computational analysis to understand connectivity patterns in your individual brain and determine how to personalize treatment to your symptoms.

Learn more about TMS therapy for depression and our approach to TMS therapy for anxiety.

Quick answer: Can TMS therapy treat co-occurring anxiety and depression?

TMS therapy may help some people who experience depression along with anxiety symptoms.

Rather than assuming the two conditions should be treated identically, your clinical team can evaluate your full symptom profile and determine which brain networks and treatment targets are most relevant.

At Neurotherapeutix, fMRI-guided TMS treatment allows that planning to reflect your individual functional brain organization rather than relying only on a standard treatment location.

Treatment response varies, and improvement in depression does not guarantee the same degree or timing of improvement in anxiety.

How common are co-occurring anxiety and depression?

Depression and anxiety are distinct conditions, but they frequently occur together.

Someone experiencing depression may also have persistent worry, tension, restlessness or fear. A person primarily seeking help for anxiety may also experience low mood, loss of interest, fatigue or feelings of hopelessness.

The National Institute of Mental Health notes that anxiety disorders can occur alongside depression and other mental health conditions. This overlap is one reason a comprehensive evaluation matters.

Having both conditions does not necessarily mean they have the same cause or involve exactly the same areas of the brain. Mental health conditions are complex, and symptom patterns can differ substantially from one person to another.

For treatment planning, the more important question is not simply: Which diagnoses do you have? It is: What does your individual symptom presentation and brain function tell us about how treatment should be approached?

How TMS therapy addresses co-occurring symptoms

Transcranial magnetic stimulation (TMS) uses magnetic pulses to influence activity within targeted areas of the brain and connected networks.

TMS is an established treatment for major depressive disorder, including for certain patients whose symptoms have not adequately improved with other treatments.

Research has also examined how TMS may affect anxiety symptoms, including anxiety occurring alongside depression.

That does not mean depression and anxiety are interchangeable or that there is one universal brain target responsible for both.

Mood regulation, emotional processing, attention, and responses to stress involve interconnected brain networks. The way those networks function can vary among patients, even when they share the same diagnoses.

At Neurotherapeutix, fMRI-guided TMS therapy is designed around that individual variability.

Instead of beginning with the assumption that every person with depression, anxiety, or both should receive stimulation in essentially the same location, we first examine how functional networks throughout your brain are communicating.

That information can then help inform an individualized treatment plan based on your brain activity, symptoms and clinical history.

Why computational brain mapping matters when symptoms overlap

Two people can both be diagnosed with anxiety and depression and still experience those conditions very differently.

One person may struggle primarily with low mood, loss of motivation and persistent worry. Another may experience physical tension, difficulty sleeping, racing thoughts and an inability to enjoy activities they once valued.

Their diagnoses may look similar on paper, but their functional brain connectivity may not.

That is where computational brain mapping becomes particularly useful.

At Neurotherapeutix, your evaluation begins with resting-state functional magnetic resonance imaging (rsfMRI). Unlike a standard structural MRI, which primarily shows brain anatomy, rsfMRI measures patterns of activity and communication among functional brain networks while you are at rest.

Our patented computational technology analyzes those connectivity patterns to identify individualized areas of interest based on your functional brain organization.

The fMRI analysis identifies individualized treatment targets within the patient’s own brain anatomy. These selected target regions are then uploaded into the neuronavigation system, allowing the clinical team to consistently position the TMS coil over the intended anatomical tissue with millimeter-level precision throughout treatment..

For someone experiencing overlapping symptoms, this whole-brain approach provides information that diagnosis alone cannot: a view of how your functional brain networks are organized.

It does not guarantee that TMS therapy will improve both anxiety and depression. Instead, it allows treatment planning to be informed by individual brain function rather than relying only on standardized targeting.

What treatment looks like for co-occurring anxiety and depression

Your treatment begins with a clinical evaluation rather than a predetermined protocol.

The Neurotherapeutix team reviews your symptoms, diagnoses, medical and psychiatric history, medications, previous treatments and response to care.

When clinically appropriate, we use computational brain mapping to evaluate your individual functional connectivity and identify potential treatment targets.

Your fMRI findings are then considered alongside your clinical presentation to develop an individualized treatment plan.

During fMRI-guided TMS therapy, magnetic pulses are delivered non-invasively while you remain awake and seated. TMS does not require surgery or anesthesia, and patients generally return to their normal activities after a session.

Your clinical response is monitored throughout treatment. When you have both depression and anxiety symptoms, those symptoms may not change at the same time or to the same degree. Tracking them individually gives your treatment team a clearer picture of how you are responding.

fMRI-guided TMS therapy may also be provided alongside other forms of care, such as psychiatric treatment, medication management or psychotherapy, when clinically appropriate.

Am I a candidate if I have both conditions?

Having both anxiety and depression does not automatically rule you out as a candidate for TMS therapy.

Candidacy depends on your individual clinical circumstances, including your diagnosis, symptoms, treatment history, medical and neurological history, current medications and other safety considerations.

At Neurotherapeutix, we also consider what your functional brain imaging shows before determining how fMRI-guided treatment may fit into your care.

Learn more about TMS therapy candidacy and what our team considers during an evaluation.

Frequently asked questions

For more information about treatment, eligibility, side effects and what to expect, explore our frequently asked questions.

Can one TMS treatment plan address both anxiety and depression?

Potentially. When depression and anxiety symptoms occur together, your clinical team can consider your complete symptom presentation when developing a TMS treatment plan.

This does not necessarily mean one stimulation target independently “treats” two diagnoses.

At Neurotherapeutix, functional brain imaging and computational analysis help determine which individualized treatment targets may be relevant based on your brain connectivity and clinical needs.

Is TMS therapy effective for anxiety that occurs alongside depression?

Research suggests TMS may improve anxiety symptoms in some patients with depression and co-occurring anxiety. However, response varies among individuals, and the evidence and regulatory status of TMS differ by condition and treatment protocol.

Your clinical evaluation can help determine whether fMRI-guided TMS therapy may be appropriate based on your diagnoses, symptoms and treatment history.

Does treating one condition improve the other?

It may, but improvement in one condition does not guarantee improvement in the other.

Anxiety and depression can interact, so changes in one group of symptoms may affect your overall functioning and well-being. However, they remain distinct clinical conditions, and each person responds differently to treatment.

Your treatment team can monitor anxiety and depressive symptoms separately throughout care to understand how each is responding.

How does Neurotherapeutix personalize treatment for comorbid symptoms?

We begin by looking beyond diagnosis alone.

Resting-state fMRI measures communication across functional networks throughout your brain. Our patented computational brain mapping technology analyzes those patterns and helps identify individualized areas of interest that may inform treatment targeting.

Your imaging findings are considered alongside your symptoms, clinical history and previous treatment response to create an individualized plan. Neuronavigation is then used during TMS therapy to consistently locate the selected treatment target.

A treatment plan built around your full symptom picture

When anxiety and depression occur together, you should not have to fit your experience into a one-size-fits-all treatment plan.

Neurotherapeutix is the only clinic in the United States offering our patented fMRI-guided TMS therapy. From our Upper East Side clinic in Manhattan, we combine whole-brain functional imaging, computational analysis and precisely targeted stimulation to personalize treatment based on your individual brain.

If you are living with depression, anxiety or both, our team can help you understand whether fMRI-guided TMS therapy may be appropriate for your needs.

Request an appointment to learn more and get started.

Trying one antidepressant after another without getting the relief you hoped for can leave you wondering why your depression has been so difficult to treat and what options are left.

When depression symptoms persist despite adequate antidepressant treatment, you may be experiencing treatment-resistant depression. This does not mean depression cannot be treated. It may mean it is time to consider a treatment that works differently.

Transcranial magnetic stimulation (TMS) therapy is a non-invasive brain stimulation treatment that may be considered when antidepressant medication has not provided sufficient relief. Rather than introducing another medication, TMS uses magnetic pulses to influence activity within brain networks involved in depression.

Quick answer: Can TMS therapy help when antidepressants haven’t worked?

Yes. TMS therapy may help some people with depression who have not experienced adequate improvement with antidepressant medication. In fact, inadequate response to antidepressant treatment is one of the circumstances in which TMS is commonly considered.

TMS works differently from medication by using magnetic stimulation to influence targeted brain activity. However, response varies, and previous medication failure does not guarantee that TMS will be effective.

A clinical evaluation can help determine whether TMS therapy may be appropriate for you.

Why antidepressants don’t work for everyone

Antidepressants are an important and effective treatment for many people with depression, but no single medication works for everyone.

The landmark STAR*D study, funded by the National Institute of Mental Health, followed patients through multiple treatment steps when their depression did not remit with an initial antidepressant. The research demonstrated an important clinical reality: some patients achieve remission with the first medication they try, while others require additional treatment strategies, and the likelihood of remission generally decreases with each successive treatment step.

The findings helped establish the need for multiple evidence-based approaches to depression when an initial medication is not enough.

There are many possible reasons an antidepressant may not provide sufficient relief.

Depression is a complex condition involving biological, psychological and environmental factors, and people can differ in their symptoms, treatment history and response to medication.

A lack of response does not necessarily tell you why a particular antidepressant did not work. It does, however, provide useful clinical information when your treatment team considers what to try next.

If adequate medication trials have not produced sufficient improvement, your clinician may discuss changing medication, psychotherapy, combination treatment, brain stimulation or other approaches based on your individual circumstances.

How TMS therapy works when medication hasn’t

Antidepressants and TMS approach depression differently.

Medication is taken systemically and affects biological processes associated with depression throughout the body and brain. TMS does not require medication to reach the brain through the bloodstream. Instead, it uses a magnetic field generated outside the head to induce electrical activity in targeted brain tissue.

For depression, conventional TMS therapy commonly targets an area of the prefrontal cortex involved in mood-related brain networks.

Repeated stimulation can influence activity within those networks over the course of treatment. Because this mechanism is different from antidepressant medication, a previous lack of response to medication does not necessarily mean you will not respond to TMS therapy.

That distinction is one reason TMS therapy may be considered for people whose symptoms have persisted despite antidepressant treatment.

At Neurotherapeutix, fMRI-guided TMS therapy adds individualized functional brain imaging and computational analysis to this process.

If you are specifically exploring treatment for persistent depression, you can also learn more about TMS therapy for depression and how Neurotherapeutix approaches treatment planning.

Why fMRI-guided TMS therapy offers a more individualized approach

Standard TMS therapy typically identifies a stimulation target using standardized anatomical measurements or scalp-based landmarks. This allows clinicians to target a general brain region associated with the condition being treated.

Neurotherapeutix takes a different approach.

Before treatment begins, resting-state functional magnetic resonance imaging (rsfMRI) measures patterns of activity and communication across functional networks throughout your brain.

Our patented computational brain mapping technology then analyzes those connectivity patterns to identify individualized areas of interest based on your functional brain organization.

The fMRI analysis identifies individualized areas of brain tissue with functional patterns relevant to the patient’s symptoms. These targets are uploaded into the neuronavigation system, allowing the treatment team to consistently and precisely position the TMS coil over the selected anatomical region with millimeter-level accuracy throughout therapy.

This means treatment planning is informed by how your individual brain is functioning rather than relying only on a standard treatment location.

For someone who has already tried several treatments without sufficient improvement, this may provide additional information not included in previous treatment planning.

However, personalized targeting does not guarantee a response to TMS therapy. The value of the approach is that it gives your clinical team an individualized view of functional brain connectivity that can help inform where treatment is delivered.

What the research says about TMS therapy after antidepressants fail

TMS has been studied extensively in depression, including among patients whose symptoms have not adequately improved with antidepressant treatment.

The FDA first cleared repetitive TMS for the treatment of major depressive disorder in adults who had not achieved satisfactory improvement from a prior antidepressant medication in the current depressive episode. Since then, TMS technologies and indications have continued to evolve.

Clinical research has found that some patients with treatment-resistant depression experience a meaningful reduction in symptoms with TMS, and some achieve remission.

Response rates vary among studies because patient populations, treatment protocols, definitions of response and other factors differ.

The key point is not that TMS will work because antidepressants did not. It is that antidepressant nonresponse does not rule out the possibility of responding to a treatment that works through a different mechanism.

Is fMRI-guided TMS therapy right for you after failed medication?

If you have tried one or more antidepressants without sufficient improvement, fMRI-guided TMS therapy may be worth discussing with a qualified clinician.

Your evaluation should consider more than the number of medications you have tried. Your treatment team may review:

• Your diagnosis and current symptoms
• How long you have experienced symptoms
• Which antidepressants and other medications you have tried
• Whether those medications were taken at adequate doses and for adequate lengths of time
• Your response to psychotherapy or other treatments
• Previous TMS or other brain stimulation treatment
• Your medical and neurological history
• Current medications and potential safety considerations

You can learn more about TMS therapy candidacy and the factors Neurotherapeutix considers before recommending treatment.

Having treatment-resistant depression does not automatically make someone a candidate for TMS, and TMS is not appropriate for everyone. An individualized clinical evaluation is the best way to determine whether it may fit into your treatment plan.

Frequently asked questions

Have additional questions about treatment, side effects or what to expect? Visit our frequently asked questions for more information about fMRI-guided TMS therapy at Neurotherapeutix.

Is TMS therapy effective if antidepressants didn’t work?

It can be.

TMS is an established treatment option for some patients with depression who have not experienced adequate improvement with antidepressant medication.

Clinical studies have shown that some people with treatment-resistant depression experience symptom improvement or remission following TMS.

However, treatment response varies, and previous antidepressant failure does not predict with certainty whether an individual patient will respond to TMS.

How is TMS therapy different from taking another medication?

The treatments work through different mechanisms.

Antidepressant medications affect biological processes associated with depression through pharmacological action. TMS uses magnetic pulses delivered from outside the head to influence activity in targeted areas of the brain and connected networks.

TMS is also non-invasive and does not require surgery or anesthesia.

Do I need to stop my current medication to try fMRI-guided TMS therapy?

Not necessarily.

Many patients receive fMRI-guided TMS therapy while continuing antidepressant or other psychiatric medication. Whether you should continue, change or discontinue a medication depends on your individual treatment plan.

Your clinician should review all medications before TMS begins because certain medications or recent medication changes may affect treatment planning or seizure risk.

Do not stop an antidepressant or change your dose on your own in preparation for TMS.

Abruptly discontinuing some antidepressants can cause withdrawal symptoms or other problems.

How soon can I start TMS therapy after stopping antidepressants?

There is no universal waiting period because you do not necessarily need to stop antidepressants before beginning TMS.

If you and the clinician managing your medication decide to reduce or discontinue a medication, the appropriate timeline depends on the specific medication, dose, how long you have been taking it, and your individual medical circumstances.

Your Neurotherapeutix team will review your current and recent medications during your evaluation and coordinate treatment planning accordingly.

Explore a different approach to persistent depression

If antidepressants have not given you the relief you hoped for, another medication is not necessarily your only next step.

Neurotherapeutix is the only clinic in the United States offering its patented fMRI-guided TMS therapy. Our approach combines whole-brain functional imaging, computational brain mapping, individualized targeting and neuronavigation to personalize treatment based on your individual brain function.

Our team can review your treatment history, discuss whether fMRI-guided TMS therapy may be appropriate and help you understand what an individualized treatment plan could look like.

Request an appointment today to learn more and get started.

When you’re considering transcranial magnetic stimulation (TMS) therapy for depression, one of the first practical questions is often how much time treatment will require.

Knowing how many sessions to expect can help you plan around work, family, travel and the financial commitment involved in care.

A standard TMS treatment course often takes place over several weeks, but there is no single session count that applies to every patient. The protocol being used, your clinical needs, and your response to treatment can all influence the course your clinician recommends.

At Neurotherapeutix, fMRI-guided TMS therapy adds functional brain imaging and individualized targeting to treatment planning.

Depending on your imaging findings and clinical needs, treatment may follow a traditional schedule or, when clinically appropriate, an accelerated protocol with multiple sessions delivered in a single day.

Quick answer: Typical TMS therapy session counts for depression

A standard course of TMS therapy for depression commonly involves treatment five days per week for approximately four to six weeks.

Depending on the protocol, this may mean roughly 20 to 30 or more treatment sessions, and some patients may benefit from additional sessions.

The exact number varies. Your clinician may consider the treatment protocol, your symptoms, previous treatment history, response to TMS and other individual factors when determining your treatment course.

Standard TMS therapy treatment timeline

Traditional TMS treatment for depression is generally delivered on an outpatient basis over several weeks.

Clinical TMS Society consensus recommendations have historically described an acute course of approximately 20 to 30 sessions over four to six weeks, although treatment may be extended when clinically appropriate.

For many patients, this means coming to the clinic five days per week. The goal is to deliver repeated stimulation over time while monitoring symptoms and clinical response.

There is no universal week when you should expect to notice improvement. Some people may begin noticing changes earlier in the treatment course, while others respond later or require additional treatment. Not experiencing an immediate change does not necessarily mean TMS will not be effective for you.

Your clinical team should monitor your progress throughout treatment rather than assuming that every patient will follow the same response timeline.

What affects how many sessions you’ll need?

There is no formula that can determine exactly how many TMS sessions you will need before treatment begins.

Your treatment plan may take several factors into account, including:

• Your diagnosis and symptoms: Your clinical presentation helps your treatment team determine which treatment approach may be appropriate.
• Your previous treatment history: Your response to antidepressants, psychotherapy, previous TMS therapy and other treatments provides important context for treatment planning.
• The TMS protocol: Different protocols use different stimulation patterns, treatment durations and schedules.
• Your response during treatment: Your clinical team can monitor changes in your symptoms and determine whether the treatment course should continue or be adjusted.
• Whether an accelerated protocol is appropriate: Some protocols deliver multiple sessions within the same day, potentially shortening the overall number of calendar days spent in treatment.

If depression has continued despite previous treatment, learning more about TMS therapy for depression can help you understand how brain stimulation may fit into a broader treatment plan.

Importantly, needing additional sessions does not mean you have failed treatment. Response to TMS varies among individuals, and your treatment course should be guided by your clinical needs rather than by reaching a predetermined number as quickly as possible.

Why fMRI-guided TMS therapy can change the treatment schedule

Standard TMS therapy typically identifies treatment targets using standardized anatomical measurements or scalp-based landmarks. Neurotherapeutix takes a different approach.

Before fMRI-guided TMS therapy begins, resting-state functional magnetic resonance imaging (rsfMRI) is used to measure patterns of activity throughout your brain while you are at rest.

The Neurotherapeutix team then uses patented computational brain mapping technology to analyze functional connectivity, or how activity in different areas of your brain is related over time.

These findings help identify individualized treatment targets based on your functional brain organization. Neuronavigation then helps the treatment team precisely locate those targets during treatment.

This is a key distinction between personalized TMS vs. standard TMS: the treatment target is informed by your individual functional brain connectivity rather than relying only on a standardized anatomical location.

However, personalized targeting does not automatically mean you will need fewer TMS sessions.

At Neurotherapeutix, imaging findings can help inform your individualized treatment plan, including the treatment target and protocol. When clinically appropriate, accelerated protocols may also be available.

An accelerated schedule generally means receiving multiple treatment sessions in one day. This can reduce the number of days required to complete treatment without necessarily reducing the total number of sessions delivered.

Your treatment team can determine which approach is appropriate based on your imaging, clinical evaluation and individual needs.

What a single fMRI-guided TMS therapy session involves

During a TMS therapy session at Neurotherapeutix, you remain awake and seated in a treatment chair. No surgery or anesthesia is required.

A magnetic coil is positioned against your scalp at the identified treatment location. The device then delivers repeated magnetic pulses to stimulate the targeted area of the brain.

During stimulation, you may hear clicking from the device and feel tapping, pressure or other sensations on your scalp. Some patients experience temporary scalp discomfort or headache, particularly early in treatment.

Session length varies according to the specific TMS protocol being used. Some standard protocols may take approximately 20 to 40 minutes, while other protocols can be shorter.

TMS is generally performed on an outpatient basis and does not require a post-treatment recovery period. Most patients can return to their usual daily activities after the session.

Frequently asked questions

Still have questions about treatment, eligibility, side effects or what to expect at Neurotherapeutix? Visit our frequently asked questions for additional information about fMRI-guided TMS therapy.

How many TMS sessions are typically needed for depression?

A standard acute course commonly involves approximately 20 to 30 or more sessions delivered over four to six weeks, often five days per week. The exact number depends on the protocol, your clinical needs and your response to treatment.

Some patients may benefit from treatment beyond the initial course, so your clinician should evaluate your progress rather than relying on a predetermined session count alone.

How long does each TMS session last?

Session length depends on the protocol being used. Some TMS sessions may take approximately 20 to 40 minutes, while other protocols can be considerably shorter.

Because TMS does not require anesthesia, patients generally do not need a recovery period afterward.

Can treatment take fewer sessions with computational brain mapping?

Not necessarily. Computational brain mapping helps Neurotherapeutix individualize where stimulation is delivered, but brain mapping alone does not establish that you will need fewer total treatment sessions.

Your imaging findings, clinical needs and response to treatment can help inform your treatment plan. When clinically appropriate, an accelerated protocol may allow multiple sessions to be delivered in one day, shortening the treatment timeline in calendar days without necessarily reducing the total number of sessions.

What happens if I don’t improve after the standard course?

Not responding within a standard treatment course does not automatically mean there are no additional options.

Your clinician can review your symptoms, treatment response and previous protocol to determine whether continued treatment, a different approach or another intervention may be appropriate.

For someone who previously received standard TMS, individualized functional imaging and targeting may also provide additional information to consider when evaluating next steps. However, fMRI-guided targeting cannot guarantee that someone who did not respond to standard TMS will respond to another course.

At Neurotherapeutix, patients are typically imaged again after completing an fMRI-guided TMS treatment course. The follow-up scan helps objectively assess treatment-related changes and guide next steps in care.

If the clinical response is incomplete, the clinical team may recommend additional treatment sessions or an updated, individualized treatment protocol that targets additional brain regions, based on the follow-up imaging findings and the patient’s symptoms.

Explore a TMS treatment plan built around your brain

There is no single TMS treatment schedule that is right for every person with depression. Understanding your symptoms, treatment history, and individual brain function can help your clinical team determine an appropriate approach.

If you are considering treatment, learn more about TMS therapy candidacy and whether brain stimulation may be appropriate for your needs.

Neurotherapeutix is the only clinic in the United States offering its patented fMRI-guided TMS therapy, combining whole-brain functional imaging, computational brain mapping, individualized targeting and neuronavigation to personalize treatment.

If you’re ready to learn what your treatment plan could look like, request an appointment with our team at our Upper East Side Manhattan clinic.

When depression symptoms continue despite treatment, it can be frustrating and difficult to understand what comes next. You may have taken one medication, waited to see whether it would help, tried another and still found yourself living with symptoms that affect your mood, energy, relationships or ability to function.

Treatment-resistant depression (TRD) is the term commonly used when depression has not adequately improved after multiple appropriate antidepressant treatments. It does not mean your depression is untreatable. It means your current approach has not provided the improvement you need, and it may be time to consider other treatment strategies.

For some people, those options may include fMRI-guided TMS therapy, which takes a different approach by using functional brain imaging and individualized targeting to inform where transcranial magnetic stimulation (TMS) is delivered.

Quick answer: What is treatment-resistant depression?

Treatment-resistant depression generally describes major depressive disorder that has not adequately improved after at least two antidepressant treatments taken at an appropriate dose, for an adequate amount of time and with appropriate adherence.

There is not one universally accepted definition of TRD, but the two-treatment threshold is commonly used in clinical and research settings.

Most importantly, treatment resistance does not mean treatment is no longer possible. Other therapeutic approaches may still help.

How is treatment-resistant depression defined?

There is no single definition of treatment-resistant depression used by every clinician or researcher. However, the U.S. Food and Drug Administration (FDA) and European Medicines Agency have used a commonly accepted definition: an inadequate response to at least two antidepressants despite adequate treatment trials and adherence.

An “adequate” medication trial generally means that the medication was taken at a therapeutic dose for enough time to reasonably evaluate its effect. The exact dose and duration depend on the medication, the individual and the clinical situation.

This distinction matters. Stopping a medication early because of side effects, taking a dose that was not therapeutically adequate or missing doses may make it difficult to determine whether the medication itself was ineffective.

Your clinician may also look beyond the number of medications you have tried. Your diagnosis, symptom severity, duration of illness, previous response to treatment, co-occurring conditions, medication tolerance and other factors can all influence how your depression is evaluated.

The National Institute of Mental Health’s landmark STAR*D study also demonstrated why reassessment becomes increasingly important when initial treatments do not produce remission.

Participants could progress through several treatment levels when earlier approaches were unsuccessful, and the likelihood of remission generally declined as additional treatment steps were required.

If your symptoms have persisted despite antidepressant treatment, learning more about TMS therapy for depression can help you understand one of the non-medication options that may be considered.

Signs you may have treatment-resistant depression

Treatment-resistant depression is not defined by having “worse” depression than someone else. Instead, the pattern of your response to treatment is an important part of the picture.

You may want to speak with your clinician about treatment-resistant depression if:

• You have completed two or more appropriate antidepressant trials without adequate improvement.
• Your symptoms improve somewhat with medication but continue to significantly affect your daily life.
• A medication initially seems helpful, but meaningful symptoms persist or return.
• Side effects make it difficult to continue otherwise appropriate medication treatment.
• You continue to experience symptoms such as persistent low mood, loss of interest or pleasure, changes in sleep, difficulty concentrating, fatigue or changes in appetite despite ongoing treatment.

These patterns do not automatically mean you have TRD. Other factors can affect treatment response, and your clinician may need to reconsider the diagnosis, look for co-occurring psychiatric or medical conditions, review medication adherence or explore other reasons your symptoms have persisted.

It can be helpful to keep a record of the antidepressants you have taken, including the dose, how long you took each medication, side effects and whether your symptoms changed. That information can give your clinician a clearer view of your treatment history.

Why some depression doesn’t respond to medication

Depression is complex, and there is no single biological explanation for why one person responds well to an antidepressant while another does not.

Genetics, neurotransmitter systems, functional brain networks, co-occurring medical or psychiatric conditions, environmental factors and differences in individual biology may all influence how depression develops and responds to treatment.

Many antidepressants affect neurotransmitter systems such as serotonin and norepinephrine. These medications can be effective for many people, but medication is not the only way to influence the systems involved in depression.

Research has also identified changes in patterns of activity and communication among brain networks involved in mood, cognition and emotional regulation.

Scientists continue to study how those patterns differ among people with depression and whether differences in functional connectivity may help explain variations in treatment response.

This broader understanding of depression is one reason brain-stimulation treatments such as transcranial magnetic stimulation have become important options for some people whose symptoms persist despite medication.

TMS does not work in the same way as an antidepressant. Instead, it uses magnetic pulses to stimulate targeted areas of the brain involved in functional networks associated with depression.

How Neurotherapeutix approaches treatment-resistant depression

At Neurotherapeutix, treatment planning begins by looking beyond diagnosis alone.

Standard TMS therapy typically identifies treatment locations using standardized anatomical measurements or scalp-based landmarks. Neurotherapeutix uses functional imaging and patented technology to take an individualized approach to treatment targeting.

The process begins with resting-state functional magnetic resonance imaging (rsfMRI). This type of functional imaging measures patterns of activity throughout the brain while you are at rest. Those patterns can be analyzed to examine functional connectivity, or how activity in different areas of your brain is related over time.

Neurotherapeutix then uses patented computational brain mapping technology to analyze those connectivity patterns and identify individualized areas of interest based on your functional brain organization.

The fMRI analysis helps identify individualized treatment targets within the patient’s own brain anatomy. These selected treatment locations are uploaded into the neuronavigation system, allowing the clinical team to consistently position the TMS coil over the intended target with millimeter-level precision throughout treatment.

This creates an important distinction between personalized TMS vs. standard TMS. Rather than relying only on a standardized treatment location, Neurotherapeutix uses whole-brain functional imaging and computational analysis to determine where to deliver stimulation for each patient.

For someone with treatment-resistant depression, this approach provides another way to think about treatment after medication has not provided adequate relief.

Research continues to examine how connectivity-based targeting may influence TMS outcomes and how individual differences in functional brain organization may inform treatment.

When to consider fMRI-guided TMS therapy for treatment-resistant depression

fMRI-guided TMS therapy may be worth discussing with our care team when depression has not adequately improved with antidepressant treatment or when medication side effects make other approaches worth exploring.

Whether and when fMRI-guided TMS therapy is appropriate depends on your diagnosis, treatment history, medical history, medications and other individual factors.

A clinical evaluation is important because TMS therapy is not appropriate for everyone, and treatment decisions should be based on your specific circumstances.

fMRI-guided TMS therapy is non-invasive and does not require surgery or anesthesia. Patients can generally return to their usual activities after a session.

If you are wondering whether your treatment history could make TMS an appropriate next step, learning about candidacy for TMS therapy can help you prepare for a conversation with your treatment team.

Frequently asked questions

Have additional questions about treatment sessions, eligibility, side effects or the Neurotherapeutix approach? Explore our frequently asked questions about TMS therapy for more information.

What qualifies as treatment-resistant depression?

Treatment-resistant depression is commonly defined as depression that has not adequately improved after at least two antidepressant treatments despite adequate dose, duration and adherence.

However, there is no single universally accepted definition. Your clinician will consider your complete treatment history rather than relying only on the number of medications you have tried.

How common is treatment-resistant depression?

Treatment-resistant depression is relatively common. Contemporary research estimates that at least 30% of people with depression may meet the commonly used definition of inadequate response to two appropriate antidepressant treatments.

The exact percentage varies among studies because researchers and clinicians have not historically used one universal definition of TRD.

Can treatment-resistant depression be treated without medication?

Medication is not the only treatment option for depression that has been difficult to treat.

Depending on your clinical needs, treatment may include psychotherapy, transcranial magnetic stimulation, electroconvulsive therapy or other approaches. Some patients may use non-medication treatments alongside medication rather than replacing it.

The appropriate approach depends on your diagnosis, previous treatment response, health history and individual needs.

Is fMRI-guided TMS therapy effective for treatment-resistant depression?

TMS is an established, non-invasive treatment option for major depressive disorder, including for patients whose depression has not adequately responded to antidepressant medication.

Treatment response varies from person to person, and no treatment can guarantee a particular outcome.

At Neurotherapeutix, fMRI-guided TMS therapy adds individualized functional brain imaging, computational brain mapping and neuronavigation to inform treatment targeting.

Rather than determining the treatment location using only standardized anatomical measurements, the approach uses information from your individual functional brain organization to guide where stimulation is delivered.

Get started with Neurotherapeutix

Treatment-resistant depression does not mean you have reached the end of your treatment options. It may mean it is time to look at your depression, your treatment history and your next steps differently.

Neurotherapeutix is the only clinic in the United States offering its patented fMRI-guided TMS approach, combining whole-brain functional imaging, computational brain mapping, individualized targeting and neuronavigation to personalize treatment.

If depression symptoms have continued despite previous treatment and you want to explore whether this approach may be appropriate for you, request an appointment with our team at our Upper East Side Manhattan clinic.

When a parent seems more forgetful, withdrawn, anxious, or simply less like themselves, it can be difficult to know what’s part of normal aging and what deserves a closer look.

Changes in mood, memory, concentration, and behavior can have many possible causes. Rather than making assumptions based on age or symptoms alone, a comprehensive evaluation can help families better understand what may be contributing to those changes.

For some adults and elderly, advanced functional brain imaging can add another layer of insight. At Neurotherapeutix, computational brain mapping helps our clinicians better understand patterns of brain function that may be relevant to treatment planning.

So, when is it worth exploring for an aging parent? Here’s what families should know.

What computational brain mapping can tell us

A traditional MRI provides detailed images of the brain’s physical structure. Functional MRI (fMRI) provides clinicians with insights into brain activity and how different areas of the brain communicate.

At Neurotherapeutix, we use resting-state functional MRI (rsfMRI) with patented computational brain mapping to evaluate these patterns of functional connectivity.

For an older adult experiencing changes in mood, memory, concentration, or behavior, this information can add to the clinical picture.

Computational brain mapping does not diagnose a condition on its own or replace a comprehensive medical or psychiatric evaluation. Instead, it provides additional information clinicians can consider when making treatment decisions.

When fMRI-guided TMS therapy is appropriate, the brain map can also be used to identify precise, individualized treatment targets rather than relying solely on a standard treatment location.

Changes that may be worth a closer look

Not every change is cause for concern, but if something feels noticeably different about your parent, it may be worth discussing with a qualified clinician.

You might notice changes such as:

• Increasing forgetfulness
• Difficulty concentrating
• Withdrawal from family, friends, or favorite activities
• Changes in mood or motivation
• Persistent anxiety
• Changes in sleep
• Mental fatigue or “brain fog”
• Difficulty keeping up with familiar daily activities

One challenge is that different conditions can sometimes produce similar symptoms. Depression and cognitive decline, for example, may both involve forgetfulness, low energy, difficulty concentrating, and changes in motivation.

That’s why these symptoms shouldn’t automatically be dismissed as aging or assumed to have a particular cause. The appropriate next step depends on your parent’s individual symptoms, medical history, and clinical evaluation.

How computational brain mapping can guide treatment

If your parent is a candidate for fMRI-guided TMS therapy, their brain map can help Neurotherapeutix identify where treatment should be focused.

TMS, or transcranial magnetic stimulation, is a non-invasive treatment that uses magnetic pulses to stimulate specific areas of the brain.

Traditional TMS typically relies on standard anatomical landmarks to determine treatment placement. Neurotherapeutix uses each patient’s functional brain imaging and patented computational brain mapping to identify precise treatment targets based on their individual brain activity and connectivity.

For an aging patient, this means treatment is informed by their own brain rather than a standard location associated with a diagnosis.

Before treatment begins, our clinicians also review relevant medical history, medications, implanted devices, and other factors to determine whether MRI and TMS therapy are appropriate.

What can your parent expect?

Knowing what actually happens during brain mapping and fMRI-guided TMS therapy can make an unfamiliar treatment feel much less intimidating.

During the brain mapping scan

Your parent will lie inside an MRI scanner while resting-state functional images are collected. There are no needles or ionizing radiation involved.

The scan gathers the data needed for computational brain mapping. Your parent’s Neurotherapeutix team will explain what to expect beforehand and answer any questions about preparing for the scan.

During fMRI-guided TMS therapy

If TMS therapy is recommended, your parent will remain awake during each treatment session. TMS does not require surgery, anesthesia, or sedation.

A TMS device is positioned on the head and delivers magnetic pulses to the treatment location identified for that patient.

Treatment schedules vary, so your parent’s clinicians will explain the recommended frequency and duration based on their individual treatment plan.

Questions to ask before moving forward

Advanced technology should have a clear clinical purpose. Before pursuing computational brain mapping or TMS therapy, you should understand why it’s being recommended and how the information will be used.

Consider asking:

• What could be contributing to my parent’s symptoms?
• Have other potential causes been evaluated?
• Why are you recommending computational brain mapping?
• What information could the scan provide?
• How could the results affect treatment decisions?
• Is my parent a candidate for fMRI-guided TMS therapy?
• What safety screening is required?
• What should we realistically expect from treatment?
• What will treatment involve?
• What are the costs?

Depending on your parent’s symptoms, a clinician may recommend other medical, psychiatric, or cognitive evaluations before or alongside advanced brain imaging.

The goal is to choose the evaluation and treatment approach that makes sense for your parent, not simply the most advanced option available.

Frequently asked questions

Is computational brain mapping safe for elderly?

Computational brain mapping at Neurotherapeutix uses data collected through resting-state functional MRI, which does not use ionizing radiation. MRI and TMS are not appropriate for everyone, however, so medical history and relevant safety factors are reviewed before proceeding.

Can computational brain mapping diagnose dementia?

No. Computational brain mapping and fMRI-based connectivity analysis are not stand-alone diagnostic tests for dementia or any specific neurodegenerative disease. Changes in memory, attention, or thinking can have many possible causes—including depression, anxiety, sleep disruption, medications, medical conditions, and neurodegenerative disorders—and require a comprehensive clinical evaluation.

However, fMRI may identify functional-connectivity patterns that extend beyond those commonly associated with depression. When interpreted alongside a patient’s symptoms, medical history, neurological examination, cognitive testing, and other appropriate studies, these findings may support further evaluation for a possible neurodegenerative process associated with cognitive decline.

Is there an age limit for fMRI-guided TMS therapy?

Age alone does not determine whether someone is an appropriate candidate for our services.

A clinician needs to consider the patient’s health history, symptoms, medications, previous treatments, implanted devices, and other relevant factors.

Will insurance cover computational brain mapping and TMS therapy?

Neurotherapeutix is a premier private clinic and operates on a self-pay basis rather than participating in insurance networks.

While we do not communicate with insurance companies directly, our team can provide detailed visit information, including superbills and relevant clinical records, for patients to submit to their insurer if they choose to pursue out-of-network reimbursement.

How do I know if my parent is a good candidate?

Start with a consultation. The Neurotherapeutix team can review your parent’s symptoms, medical history, previous treatments, and goals and determine whether additional evaluation or fMRI-guided TMS therapy may be appropriate.

Is computational brain mapping the right next step for your parent?

There isn’t one answer for every older adult.

For some patients, computational brain mapping may provide useful additional information that helps clinicians make more informed treatment decisions. For others, a different evaluation or treatment may be more appropriate.

That’s why Neurotherapeutix starts with the individual, not the technology.

As the only clinical practice in the United States offering patented computational brain mapping to personalize fMRI-guided TMS therapy, Neurotherapeutix brings together advanced functional brain imaging and experienced clinical evaluation to determine whether this approach may be appropriate for each patient.

If you’re concerned about changes in your parent’s mood, memory, concentration, or behavior, a consultation can help you better understand the options available.

Request an appointment with Neurotherapeutix in Manhattan to start the conversation.

Deciding to explore a new mental health treatment can bring up a lot of questions. Explaining that decision to the people closest to you can sometimes feel even more complicated.

Your family may be unfamiliar with computational brain mapping or fMRI-guided TMS therapy. They may wonder what the technology does, why you’re considering it, whether it’s safe, or how it differs from treatments you’ve already tried.

You don’t need to become an expert before starting the conversation. A simple explanation of what you’re considering, why you’re considering it, and what you hope to learn can give your family a better understanding of your decision.

If you’re still learning about your options, you can also explore our services before deciding which questions you want to discuss together.

Why these conversations can be difficult

Mental health treatment can be personal. Family members may have their own experiences, expectations, or concerns, and newer technologies can add another layer of uncertainty.

Sometimes hesitation comes from simply not understanding what terms like “brain mapping” or “TMS” mean.

A loved one may hear “brain stimulation” and imagine a much more invasive procedure. Others may wonder why another approach is necessary when medications, psychotherapy, or other treatments are already available.

It can help to remember that questions aren’t necessarily opposition. Often, they’re an attempt to understand something unfamiliar.

Instead of beginning with the science, start with your own experience. Explain what you’ve been dealing with, what you’ve already tried, and why you’re interested in learning about another option.

You might say: “I’ve been looking into another treatment option because I want to better understand what may work for me. It uses brain imaging to help guide treatment based on how my own brain is functioning.”

That gives your family a place to begin without overwhelming them with clinical terminology.

What is computational brain mapping treatment? A simple explanation

One of the easiest ways to explain computational brain mapping is to separate the imaging from the treatment.

At Neurotherapeutix, resting-state functional MRI (rsfMRI) is used in combination with patented computational brain mapping to examine patterns of brain activity and how different areas of the brain communicate.

Think of the brain map as information. It gives our clinicians a more detailed picture of your individual brain function that can be considered alongside your symptoms, history, previous treatments, and clinical evaluation.

The map itself is not a treatment.

When clinically appropriate, those insights can then be used to help identify precise treatment targets for fMRI-guided TMS therapy.

TMS, or transcranial magnetic stimulation, is a non-invasive treatment that uses magnetic pulses to stimulate specific areas of the brain. Standard TMS therapy typically uses general anatomical landmarks to determine treatment placement. Neurotherapeutix uses each patient’s functional brain data to help determine where treatment should be focused.

A simple way to explain the process to your family is: “The scan helps my doctors understand how different areas of my brain are communicating. If TMS therapy is right for me, they can use that information to identify a precise treatment target.”

That’s usually enough information for a first conversation. You can always go deeper into the science later.

Explaining the benefits to a loved one

When talking with family, focus less on how sophisticated the technology is and more on why having additional information matters to you.

You may be interested in computational brain mapping because previous treatments haven’t provided sufficient relief.

You may want to understand all of your options before making another treatment decision.

Or you may value an approach that considers information from your individual brain rather than relying only on a diagnosis.

The important distinction is that Neurotherapeutix doesn’t use computational brain mapping simply to create an image of the brain. The information has a clinical purpose: when TMS therapy is appropriate, it can help clinicians identify precise, individualized treatment targets.

Learning more about how computational brain mapping personalizes TMS therapy may also help your family understand why you’re considering this approach.

Try keeping the conversation centered on your reason for exploring it: “I’m not committing to a treatment just because the technology is advanced. I’m interested because it may give my doctors more information to make a treatment decision based on my individual brain.”

That distinction can be especially helpful for family members who are skeptical of treatments they haven’t encountered before.

Addressing common questions and concerns

Questions are a normal part of considering any treatment. You don’t need to have every answer yourself, but understanding a few basics can make the conversation easier.

Is it safe?

Computational brain mapping at Neurotherapeutix uses functional MRI. MRI uses magnetic fields and radio waves to create images and does not expose patients to ionizing radiation.

The mapping process itself gathers information. It does not stimulate or alter the brain.

TMS therapy is a separate process. It is non-invasive and does not require surgery, anesthesia, or sedation. Before either MRI or TMS therapy is recommended, clinicians consider medical history and relevant safety factors to determine whether the procedure is appropriate.

Research also supports the use of functional brain imaging to help individualize TMS treatment targets.

In a 2025 study of patients with treatment-resistant depression, researchers used each patient’s fMRI connectivity data to personalize the stimulation site and reported significant reductions in depression symptoms following treatment.

Will treatment change who they are?

This concern may come up when a family first hears terms such as “computational brain mapping” or “brain stimulation.”

Computational brain mapping does not change the brain or a person’s personality. It collects information about brain activity and connectivity that clinicians can use as part of treatment planning.

If your family is asking about TMS therapy, explain that the goal is not to change who someone is. TMS is used to stimulate specific areas of the brain associated with the condition being treated.

For patients receiving other forms of treatment as well, learning about combining computational brain mapping with psychotherapy can help families understand how different elements of a treatment plan may work together.

What does fMRI-guided TMS therapy involve?

If fMRI-guided TMS therapy is recommended, treatment takes place over a series of sessions.

During each session, the patient remains awake while a TMS device positioned on the head delivers magnetic pulses to the treatment area. There is no surgery or anesthesia, and patients can typically return to their regular activities after a session.

The recommended treatment schedule depends on the individual patient, condition, and treatment plan. Your Neurotherapeutix clinician can explain what to expect based on your specific circumstances.

Supporting a loved one through treatment

Family support doesn’t require understanding every detail of the technology.

Often, the most valuable thing you can do is listen.

Ask your loved one what kind of support would actually be useful. They may appreciate help getting to appointments, someone to talk with afterward, or simply knowing that they don’t have to continually explain or defend their treatment decision.

Try not to monitor every good or bad day as evidence that treatment is or isn’t working. Response to fMRI-guided TMS therapy can vary, and progress should be evaluated with the clinical team over time.

You can also learn more together about how fMRI-guided TMS therapy fits into a holistic mental health plan, particularly if your loved one is also participating in psychotherapy, psychiatric care, medication management, or other forms of support.

Most importantly, allow the person receiving treatment to remain at the center of the decision. Being involved doesn’t mean taking over. It means helping them feel informed, respected, and supported.

Frequently asked questions

How do I bring up computational brain mapping treatment with a resistant family member?

Start with why you’re considering it rather than trying to convince them of the technology.

You might explain what you’ve already tried, what you’re hoping to improve, and why having more individualized information about your brain is meaningful to you.

If they have concerns you can’t answer, write the questions down and bring them to your consultation. You don’t need to resolve every concern in one conversation.

What role can family play during fMRI-guided TMS therapy?

That depends on what the person receiving treatment wants.

Family members may help with transportation, appointments, practical responsibilities, or simply emotional support. They can also help keep track of questions to discuss with the clinical team.

The most helpful approach is usually to ask rather than assume what kind of involvement is wanted.

Where can my family learn more before deciding?

Start with reliable medical information and the specific treatment information provided by your clinical team.

Neurotherapeutix can explain how computational brain mapping and fMRI-guided TMS therapy are used within our practice, while independent organizations such as the National Institute of Mental Health provide broader educational information about brain stimulation therapies.

Your family can also review the Neurotherapeutix services together and bring any questions to an initial consultation.

Make the decision together, without losing sight of who it’s for

Family can be an important source of support when you’re considering a new treatment, but ultimately, the decision should center on the person receiving it.

Give everyone room to ask questions. Learn about the technology together. Talk openly about your concerns and expectations. And rely on qualified clinicians to help you understand what is and isn’t appropriate for your individual situation.

Neurotherapeutix is the only clinical practice in the United States offering patented computational brain mapping to personalize fMRI-guided TMS therapy.

Our Manhattan team uses advanced functional brain imaging alongside comprehensive clinical evaluation to help determine whether this approach may be appropriate for you.

Learn more about TMS therapy in Manhattan and the treatment options available at Neurotherapeutix, or request an appointment to start the conversation.

Kanye West’s bipolar story and brain mapping

Bipolar disorder has been part of the public conversation for years, but few stories have sparked as much discussion as Kanye West’s.

His openness about his mental health diagnosis has put a spotlight on the challenges of mood disorders and the need for more individualized, neuroscience-based approaches to care.

At Neurotherapeutix in New York City, our team uses patented fMRI-based computational brain mapping to better understand the neural patterns behind bipolar disorder and create individualized treatment plans.

To learn how brain-based technologies may support mood stabilization, contact our team or continue reading below.

Why Kanye West’s bipolar diagnosis matters today

Kanye West’s diagnosis has played a major role in increasing awareness of bipolar disorder. His public experiences, ranging from creative highs to moments of emotional overwhelm, help people understand that bipolar disorder is complex, unpredictable and deeply rooted in how the brain regulates mood.

Public impact of his mental health journey

West’s transparency has encouraged more people to talk openly about their own mental health challenges. It has also shown how untreated or under-treated symptoms can affect relationships, decision-making, work and daily life.

His story highlights the importance of timely support and access to personalized, neuroscience-based care.

What his story reveals about mood disorders

Mood disorders do not follow a simple pattern. Some individuals experience long periods of stability, while others cycle quickly between highs and lows.

West’s journey reflects how mood, impulse control and emotional regulation can shift unexpectedly, often driven by underlying changes in brain activity and connectivity.

According to the National Institute of Mental Health, about 2.8 percent of U.S. adults experience bipolar disorder each year, making it one of the most common mood disorders that impacts both emotional and cognitive function.

Understanding bipolar disorder and brain function

Bipolar disorder is categorized as a mood disorder characterized by episodes of depression, mania or hypomania. Behind these symptoms are specific brain circuits that influence emotional regulation, energy levels, sleep, motivation and judgment.

How bipolar disorder affects mood-regulating circuits

Research shows that bipolar disorder involves changes in communication across the prefrontal cortex, amygdala and limbic system—areas responsible for decision-making, emotional responses and stress processing. When these circuits become dysregulated, mood states can shift rapidly or intensely.

Mood disorder brain patterns explained

Imaging studies have identified patterns of overactivity in regions associated with emotional reactivity and underactivity in areas linked to cognitive control. These patterns vary widely between individuals, which is why bipolar disorder looks different for each person and why personalized assessment is so important.

What is brain mapping and how does it work?

Brain mapping is an emerging tool that uses advanced imaging to study how different parts of the brain communicate.

At Neurotherapeutix, computational brain mapping is used exclusively as a part of our fMRI-based analysis to measure functional connectivity with millimeter-level precision. It is not a standalone treatment.

How brain imaging identifies functional abnormalities

Functional MRI tracks changes in blood flow that reflect neural activity. By analyzing these patterns, clinicians can identify circuits involved in mood regulation, stress response and cognitive processing. This helps reveal why specific symptoms appear or why certain treatments may not be effective.

Technology used in brain mapping therapy

Computational brain mapping uses detailed algorithms to interpret fMRI data, creating a personalized view of how a patient’s neural networks function. This goes beyond surface-level imaging to uncover connectivity issues that may contribute to mood instability.

Brain mapping vs. traditional psychiatric evaluation

Traditional evaluations rely on symptom descriptions, history and behavioral observations. Brain mapping adds an objective layer of information, providing neural data that can help clinicians understand the biological components of bipolar disorder and tailor treatment more precisely.

Brain mapping for bipolar disorder

Brain mapping is increasingly explored as a tool to improve diagnostic clarity and inform targeted interventions for bipolar disorder.

Why personalized brain data matters for treatment

Because bipolar disorder varies widely, having precise neural information helps clinicians guide treatment more effectively. Personalized data can highlight which circuits are overactive, underactive or misaligned, offering insight into what approaches may best support mood stabilization and strengthen neural connections.

At Neurotherapeutix, computational brain mapping is used to identify mood-related connectivity patterns that may not appear on standard imaging. This detailed view helps our team understand the unique functional changes contributing to each patient’s symptoms.

Neuroplasticity and brain-based stabilization

One of the key goals of brain-based treatment is to support neuroplasticity—the brain’s ability to adapt and strengthen healthier communication between circuits.

By identifying specific areas involved in mood regulation, clinicians can use targeted treatments to support long-term stability.

Personalized treatment options based on brain mapping

Brain mapping can guide a range of customized treatment approaches, offering insight into what is most effective for each individual.

Tailoring medication and therapy to brain activity patterns

Brain data may help clinicians better understand how a patient responds to medication or why certain symptoms persist. This supports more informed decision-making and reduces trial-and-error approaches.

Neurofeedback for bipolar disorder

Some individuals benefit from neurofeedback, a technique that trains the brain to regulate activity more effectively. By providing real-time information about neural patterns, neurofeedback may help patients develop greater control over stress responses and emotional regulation.

Brain-based approaches for mood stabilization

In some cases, targeted neuromodulation, such as fMRI-guided TMS therapy, can be used to stimulate specific circuits involved in mood regulation. This noninvasive approach is tailored using computational brain mapping data.

How Kanye West’s story reflects new mental health approaches

Kanye West’s public journey illustrates both the challenges of bipolar disorder and the importance of exploring innovative treatment modalities.

Why traditional bipolar treatments fall short for some patients

Standard medications and therapy are effective for many people, but not all individuals respond fully. This can happen when symptoms stem from neural circuits that are not being adequately addressed by conventional treatment alone.

How neuroscience-based models offer more precision

Neuroscience-based models look at the root causes of mood shifts by studying specific brain connections. Instead of general treatment paths, these models offer personalized approaches that reflect each person’s neural patterns.

When to consider brain mapping for bipolar disorder

Brain mapping may be helpful for individuals who:

• • Have persistent symptoms despite treatment
• • Experience rapid-cycling episodes
• • Want a clearer understanding of their brain’s role in mood changes
• • Are exploring individualized or advanced interventions
• • Want to complement traditional care with neuroscience-based approaches

Mapping provides a deeper look at functional connectivity and can guide next steps in care.

Effective and personalized brain mapping therapy in NYC

Located on Manhattan’s Upper East Side, Neurotherapeutix provides advanced, noninvasive computational brain mapping and neuroscience-driven treatments for individuals navigating bipolar disorder.

Our approach combines patented fMRI technology with compassionate, expert-led care to support mood stability and long-term well-being.

If you or a loved one is exploring personalized options for bipolar disorder treatment, contact our team to learn how computational brain mapping may support your goals.

Frequently asked questions

Artists, athletes and individuals across all backgrounds often want to understand how brain-based tools fit into bipolar disorder care. Here are answers to commonly asked questions.

Does brain mapping replace medication for bipolar disorder?

No. Brain mapping does not replace medication, but it may provide additional insight into how the brain functions, helping clinicians tailor care more effectively.

How accurate is brain mapping for mood disorder diagnosis?

Computational brain mapping offers functional insights but is not a standalone diagnostic tool. It complements clinical evaluation by revealing connectivity patterns involved in mood regulation.

Can brain mapping show why medications are not working?

In some cases, mapping can highlight neural circuits that remain dysregulated despite treatment, helping clinicians adjust care with more precision.

Is brain mapping helpful for people with rapid-cycling bipolar disorder?

Mapping may help identify fast-shifting connectivity patterns that contribute to rapid mood changes, offering a clearer picture of the underlying neural activity.

How long does it take to see results from brain-based therapy?

Timelines vary. Some individuals begin noticing changes after several weeks of targeted treatment, while others may need a longer course based on their symptoms and brain data.

Mental health in sports is receiving more attention than ever before.

Much of that shift began when world–class athletes like Naomi Osaka and Simone Biles openly shared their struggles with anxiety, burnout and the pressure that comes with performing on the world’s biggest stages.

Their stories sparked a global conversation about athlete mental health and highlighted the need for treatment approaches that support the brain as much as the body.

At Neurotherapeutix in New York City, our team uses advanced, neuroscience-driven and brain-based mental health interventions to help individuals understand how anxiety affects their brains and explore personalized, noninvasive treatment options.

To learn how brain-based interventions may support recovery, contact our team or continue reading below.

Why athlete mental health is in the spotlight today

Mental health in sports is no longer a quiet conversation.

Over the last several years, elite athletes have begun openly discussing the emotional challenges of competing at the highest level.

Their honesty has shifted public expectations, encouraged more athletes to seek support and revealed the vital role mental well-being plays in long-term performance, safety and overall health.

Rising awareness through public athlete disclosures

For years, athletes were expected to stay silent about mental health challenges. That changed when global icons began speaking honestly about their experiences.

Naomi Osaka’s withdrawal from major tournaments to protect her mental health and Simone Biles stepping back during the Olympics opened a new conversation about what anxiety looks like, even for the most decorated competitors in the world.

Their openness helped reduce stigma, showing fans, coaches and fellow athletes that prioritizing mental health is a sign of strength, not weakness.

The mental health cost of elite performance

High-level sports are both physically demanding and mentally taxing.

Behind every competition are years of training, strict routines, travel and constant evaluation from coaches, fans and the media. Over time, that level of scrutiny and pressure can push even the most resilient athletes toward anxiety, exhaustion and emotional strain.

According to a 2016 narrative systematic review in Sports Medicine by Rice and colleagues, elite athletes face a unique range of stressors, including injury, overtraining, burnout, intense public scrutiny and ongoing competitive pressure, that may increase their vulnerability to mental health problems.

For many athletes, these challenges build slowly. What begins as “normal nerves” before a big event can evolve into persistent worry, sleep disruption, physical tension or loss of enjoyment in the sport. When that happens, anxiety is no longer just part of competing—it becomes a barrier to both performance and quality of life.

Naomi Osaka’s experience with anxiety

Naomi Osaka has been clear about how public pressure, expectations and constant visibility affected her mental health.

Her decision to withdraw from the 2021 French Open to protect her emotional well-being revealed how anxiety can build behind the scenes, even when an athlete appears calm and composed on the court.

What her story reveals about athlete pressure

Osaka’s honesty highlights a truth many athletes share: anxiety isn’t just about stress.
It can affect sleep, focus, appetite, confidence and the ability to perform under pressure.

For athletes who are always “on,” anxiety often comes from both internal expectations and external demands, creating a cycle that can be difficult to break without support.

Simone Biles and the reality of performance anxiety

Simone Biles has spoken openly about experiencing anxiety, including moments where her stress levels were so high that she felt unsafe competing.

During the Tokyo Olympics, she described experiencing symptoms that disrupted her mind-body awareness — a reminder that anxiety can have very real physical effects.

What her anxiety attack revealed about athlete stress

For gymnasts, divers, skaters and others who depend on timing and spatial awareness, even a brief lapse in concentration can increase the risk of injury.

Biles’ experience showed the world that anxiety isn’t only emotional, it can directly affect coordination, focus and the ability to perform complex movements safely.

Why athletes struggle with anxiety differently

Athletes experience anxiety in ways that can be more intense or more complex than in the general population.

High-performance expectations and public scrutiny

Competitions, media commentary, sponsorships and national expectations all compound stress. Athletes carry both personal and public pressure.

Athlete burnout and chronic stress load

Years of training without sufficient mental recovery can lead to emotional exhaustion, decreased motivation and physical tension — all factors that increase anxiety risk.

Impact on confidence, focus and identity

Many athletes tie their identity to performance. When anxiety affects their sport, it may also impact their self-esteem and sense of purpose.

How anxiety impacts athletic performance

Anxiety affects much more than how an athlete feels — it influences how the brain processes information, controls movement and responds to stress.

During high-stakes moments, these changes can disrupt timing, coordination, decision-making and confidence, making it harder for athletes to perform consistently.

Understanding these effects helps athletes recognize when anxiety becomes more than everyday nerves and when specialized support may be needed.

Effects on motor control, timing and concentration

Anxiety activates the body’s stress response, which can affect reaction time, focus, fine motor skills and overall coordination. In precision-based sports, this can quickly disrupt performance.

How brain-body stress responses affect competition

Stress hormones influence muscle tension, breathing patterns and cognitive processing.
For high-performance athletes, even a slight shift in these systems can alter execution, affecting everything from speed and accuracy to form and decision-making.

New brain-based interventions for athlete anxiety

Advances in neuroscience have expanded the range of treatments available for anxiety, giving athletes new, evidence-based options that address not only symptoms but also the underlying neural circuits involved.

What brain-based mental health interventions involve

These approaches focus on understanding how different parts of the brain communicate and how stress affects those connections. They use tools that support neural regulation and help strengthen healthier pathways.

Neuroscience-based anxiety therapy explained

For some individuals, functional MRI–based computational brain mapping can reveal patterns of overactivity or underactivity in regions associated with emotional regulation, stress response and cognitive control.

Identifying these patterns can guide targeted, noninvasive treatments that support healthier communication between brain regions.

Advanced brain-based treatments used today

At Neurotherapeutix, fMRI-guided transcranial magnetic stimulation (TMS) therapy uses this imaging data to personalize treatment for each patient.

Unlike traditional TMS, which uses a standard coil placement, fMRI-guided TMS identifies the specific circuits involved in a patient’s symptoms, allowing clinicians to tailor stimulation with millimeter-level precision.

This approach supports neuroplasticity — the brain’s natural ability to form new connections — and may help many individuals experience improvement in anxiety symptoms.

How neuroscience helps athletes recover from anxiety

Brain-based treatments focus on strengthening the networks responsible for emotional regulation, focus and stress resilience.

By targeting the circuits involved in anxiety, these interventions can help restore balance in the brain’s communication pathways, giving athletes a clearer ability to manage high-pressure situations.

For many individuals, this means better emotional stability, improved concentration and greater confidence during both training and competition.

When athletes should seek anxiety support

An athlete may benefit from professional support when anxiety begins to:

• • Affect performance
• • Disrupt sleep or appetite
• • Create physical symptoms such as muscle tension or dizziness
• • Lead to panic or overwhelming worry
• • Interfere with focus, timing or coordination

Early help can prevent symptoms from escalating and provide athletes with tools to navigate future stressors more effectively.

Anxiety treatment for athletes in NYC

Located on Manhattan’s Upper East Side, Neurotherapeutix offers advanced, noninvasive treatment options for individuals navigating performance-related anxiety.

Our patented fMRI-based computational brain mapping and precision-guided TMS therapy allow us to personalize anxiety care in ways that reflect each patient’s unique brain function.

If you or a loved one is exploring anxiety treatment options, contact our team to learn more about how neuroscience-based care may support your goals.

Frequently asked questions

Athletes and their families often have questions about how neuroscience-based treatments work, what they involve and whether they are safe for competitive training schedules.

Below are answers to some of the questions we hear most often about anxiety care, performance stress and brain-based interventions.

Can brain-based treatments help athletes manage performance anxiety?

Brain-based treatments can support emotional regulation and improve communication in neural circuits involved in anxiety. Many athletes find these approaches helpful in managing high-pressure situations.

How long do neuroscience-based anxiety therapies take to work?

Treatment timelines vary, but many patients complete a series of sessions over several weeks. Each plan is personalized based on imaging data and clinical needs.

Are these treatments safe for professional and competitive athletes?

Yes. fMRI-guided TMS therapy is noninvasive and does not require medication or recovery time, allowing athletes to continue their normal routines.

Can athletes continue training while receiving anxiety treatment?

Most individuals can continue training as usual. The Neurotherapeutix team can coordinate care around practice and competition schedules.

What makes athlete anxiety different from general anxiety disorders?

Athlete anxiety is shaped by performance pressure, public visibility and physical demands. These factors can affect both emotional well-being and the cognitive-motor skills required for competition.